Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Marinho, Vanessa F Z ^a   Metze, Konradin ^b   Sanches, Fernanda S F ^a   Rocha, Gislene F S ^a   Gobbi, Helenice ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HEMATOXYLIN; KI 67 ANTIGEN; MONOCLONAL ANTIBODY D2-40; PROGESTERONE RECEPTOR; PROTEIN P53; UVOMORULIN; DIAGNOSTIC AGENT; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; ONCOFETAL ANTIGENS; TUMOR ANTIGEN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER GRADING; CANCER INVASION; CLINICAL INDICATOR; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MICROMETASTASIS; PATIENT SELECTION; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RELIABILITY; AXILLA; BLOOD VESSEL; BREAST TUMOR; CHEMISTRY; COMPARATIVE STUDY; ENDOTHELIUM CELL; ENZYME IMMUNOASSAY; IMMUNOLOGY; METASTASIS; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; TUMOR EMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; AXILLA; BLOOD VESSELS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; ENDOTHELIAL CELLS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 42349109578     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-64     Document Type: Article

References (43)

1. Schoppmann SF Bayer G Aumayr K Taucher S Geleff S Rudas M Kubista E Hausmaninger H Samonigg H Gnant M Jakesz R Horvat R Austrian Breast and Colorectal Cancer Study Group Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer Ann Surg 2004, 240:306-312. 1356408 15273556 10.1097/01.sla.0000133355.48672.22
2. Aoki Y Tosato G Lymphatic regeneration: New insights from VEGFR-3 blockade J Natl Cancer Inst 2005, 97:2-3. 15632367
3. Vleugel MM Bos R van der Groep P Greijer AE Shvarts A Stel HV van der Wall E van Diest PJ Lack of lymphangiogenesis during breast carcinogenesis J Clin Pathol 2004, 57:746-751. 1770348 15220369 10.1136/ jcp.2003.014480
4. Yonemura Y Endou Y Tabachi K Kawamura T Yun HY Kameya T Hayashi I Bandou E Sasaki T Miura M Evaluation of lymphatic invasion in primary gastric cancer by a new monoclonal antibody, D2-40 Hum Pathol 2006, 37:1193-1199. 10.1016/j.humpath.2006.04.014 16938525
5. Arnaout-Alkarain A Kahn HJ Narod SA Sun PA Marks AN Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer Mod Pathol 2007, 20:183-191. 10.1038/modpathol.3800728 17206106
6. Choi WW Lewis MM Lawson D Yin-Goen Q Birdsong GG Cotsonis GA Cohen C Young AN Angiogenic and lymphangiogenic microvessel density in breast carcinoma: Correlation with clinicopathologic parameters and VEGF-family gene expression Mod Pathol 2005, 18:143-152. 10.1038/modpathol.3800253 15297858
7. Cunnick GH Jiang WG Gomez KF Mansel RE Lymphangiogenesis and breast cancer metastasis Histol Histopathol 2002, 17:863-870. 12168797
8. Franchi A Gallo O Massi D Baroni G Santucci M Tumor lymphangiogenesis in head and neck squamous cell carcinoma: A morphometric study with clinical correlations Cancer 2004, 101:973-978. 10.1002/cncr.20454 15329906
9. Cursiefen C Schlotzer-Schrehardt U Kuchle M Sorokin L Breiteneder-Geleff S Alitalo K Jackson D Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin Invest Ophthalmol Vis Sci 2002, 43:2127-2135. 12091407
10. Ebata N Nodasaka Y Sawa Y Yamaoka Y Makino S Totsuka Y Yoshida S Desmoplakin as a specific marker of lymphatic vessels Microvasc Res 2001, 61:40-48. 10.1006/mvre.2000.2280 11162194
11. Jussila L Alitalo K Vascular growth factors and lymphangiogenesis Physiol Rev 2002, 82:673-700. 12087132
12. Wigle JT Oliver G Prox1 function is required for the development of the murine lymphatic system Cell 1999, 98:769-778. 10.1016/ S0092-8674(00)81511-1 10499794
13. Kahn HJ Marks A A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors Lab Invest 2002, 82:1255-1257. 12218087
14. Kahn HJ Bailey D Marks A Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas Mod Pathol 2002, 15:434-440. 10.1038/modpathol.3880543 11950918
15. Agarwal B Saxena R Morimiya A Mehrotra S Badve S Lymphangiogenesis does not occur in breast cancer Am J Surg Pathol 2005, 29:1449-1455. 10.1097/ 01.pas.0000174269.99459.9d 16224211
16. Yamauchi C Hasebe T Iwasaki M Imoto S Wada N Fukayama M Ochiai A Accurate assessment of lymph vessel tumor emboli in invasive ductal carcinoma of the breast according to tumor areas, and their prognostic significance Hum Pathol 2007, 38:247-259. 10.1016/j.humpath.2006.07.017 17056095
17. Schacht V Dadras SS Johnson LA Jackson DG Hong YK Detmar M Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors Am J Pathol 2005, 166:913-921. 1602360 15743802
18. Van den Eynden GG Van der Auwera I Van Laere SJ Colpaert CG van Dam P Dirix LY Vermeulen PB Van Marck EA Distinguishing blood and lymph vessel invasion in breast cancer: A prospective immunohistochemical study Br J Cancer 2006, 94(11):1643-1649. 16670715 16670715
19. Evangelou E Kyzas PA Trikalinos TA Comparison of the diagnostic accuracy of lymphatic endothelial markers: Bayesian approach Mod Pathol 2005, 18:1490-1497. 10.1038/modpathol.3800457 15990898
20. Van der Auwera I Van den Eynden GG Colpaert CG Van Laere SJ van Dam P Van Marck EA Dirix LY Vermeulen PB Tumor lymphangiogenesis in inflammatory breast carcinoma: A histomorphometric study Clin Cancer Res 2005, 11:7637-7642. 10.1158/1078-0432.CCR-05-1142 16278382
21. Nisato RE Tille JC Pepper MS Lymphangiogenesis and tumor metastasis Thromb Haemost 2003, 90:591-597. 14515178
22. Fukunaga M Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours Histopathology 2005, 46:396-402. 10.1111/ j.1365-2559.2005.02098.x 15810951
23. Greene FL Page DL Fleming ID Fritz AG Balch CM Haller DG Morrow M Breast AJCC Cancer Staging Manual New York: Springer Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M 6 2002, 223-240.
24. Page DL Jensen RA Simpson JF Routinely available indicators of prognosis in breast cancer Breast Cancer Res Treat 1998, 51:195-208. 10.1023/ A:1006122716137 10068079
25. Fitzgibbons PL Page DL Weaver D Thor AD Allred DC Clark GM Ruby SG O'Malley F Simpson JF Connolly JL Hayes DF Edge SB Lichter A Schnitt SJ Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999 Arch Pathol Lab Med 2000, 124:966-978. 10888772
26. Elston CW Ellis IO Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up Histopathology 1991, 19:403-410. 10.1111/j.1365-2559.1991.tb00229.x 1757079
27. Van der Auwera I Cao Y Tille JC Pepper MS Jackson DG Fox SB Harris AL Dirix LY Vermeulen PB First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours Br J Cancer 2006, 95:1611-1625. 10.1038/sj.bjc.6603445 17117184
28. Allred DC Harvey JM Berardo M Clark GM Prognostic and predictive factors in breast cancer by immunohistochemical analysis Mod Pathol 1998, 11:155-168. 9504686
29. Harvey JM Clark GM Osborne CK Allews DC Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer J Clin Oncol 1999, 17:1474-1481. 10334533
30. Keshgegian AA Cnaan A Proliferation markers in breast carcinoma. Mitotic figure count, S-Phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1 Am J Clin Pathol 1995, 104:42-49. 7611179
31. Dako Herceptest™ A manual for interpretation 1999.
32. Gupta A Deshpande CG Badve S Role of E-Cadherins in development of lymphatic tumor emboli Cancer 2003, 97:2341-2347. 10.1002/cncr.11332 12712492
33. Lorand-Metze I Meira DG Lima CS Vassallo J Metze K The differential diagnosis between aplastic anemia and hypocellular myelodysplasia in patients with pancytopenia Haematologica 1999, 84:564-565. 10366807
34. Delamain MT Metze K Marques JF Reis AR De Souza CA Lorand-Metze I Optimization of CD34+ collection for autologous transplantation using the evolution of peripheral blood cell counts after mobilization with chemotherapy and G-CSF Transfus Apher Sci 2006, 34:33-40. 10.1016/ j.transci.2005.09.004 16376618
35. Tezuka K Onoda N Takashima T Takagaki K Ishikawa T Wakasa T Wakasa K Hirakawa K Prognostic significance of lymphovascular invasion diagnosed by lymphatic endothelium immunostaining in breast cancer patients Oncol Rep 2007, 17:997-1003. 17390035
36. Acs G Dumoff KL Solin LJ Pasha T Xu X Zhang PJ Extensive retraction artifact correlates with lymphatic invasion and nodal metastasis and predicts poor outcome in early stage breast carcinoma Am J Surg Pathol 2007, 31:129-140. 10.1097/01.pas.0000213316.59176.9b 17197929
37. Siitonen SM Kononen JT Helin HJ Rantala IS Holli KA Isola JJ Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer Am J Clin Pathol 1996, 105:394-402. 8604681
38. Charpin C Garcia S Bouvier C Devictor B Andrac L Choux R Lavaut M E-cadherin quantitative immunocytochemical assays in breast carcinomas J Pathol 1997, 181:294-300. 10.1002/ (SICI)1096-9896(199703)181:3<294::AID-PATH772>3.0.CO;2-V 9155715
39. Qureshi HS Linden MD Divine G Raju UB E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters Am J Clin Pathol 2006, 125:377-385. 10.1309/ WMX7-DRWT-FVQP-2LQT 16613340
40. Pepper MS Lymphangiogenesis and tumor metastasis: Myth or reality? Clin Cancer Res 2001, 7:462-468. 11297234
41. Niakosari F Kahn HJ Marks A From L Detection of lymphatic invasion in primary melanoma with monoclonal antibody D2-40: A new selective immunohistochemical marker of lymphatic endothelium Arch Dermatol 2005, 141:440-444. 10.1001/archderm.141.4.440 15837861
42. Goldhirsch A Glick JH Gelber RD Coates AS Thurlimann B Senn HJ Panel members Meeting highlights: International expert consensus on the primary therapy of early breast cancer 2005 Ann Oncol 2005, 16:1569-1583. 10.1093/annonc/mdi326 16148022
43. Zeng Y Opeskin K Horvath LG Sutherland RL Williams ED Lymphatic vessel density and lymph node metastasis in prostate cancer Prostate 2005, 65:222-230. 10.1002/pros.20288 15948136